Loading
Latest filing published 29 Jul 2022 for Welbilt, Inc., €1.0M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Brian R. Gamache across 2 companies, led by Welbilt, Inc. and P3 Health Partners Inc. In total, 3 filings cover trades dated from 4 October 2021 to 28 July 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 29 July 2022, the filings show a transaction worth €1.0M in Welbilt, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations